Skip to content
Biodatica
Start free

Johnson & Johnson Private Limited

Bangalore

OncologyFiled/ApprovedListed · JNJ

This company trades under its own ticker, so it sits outside Biodatica’s pre-ticker window. The record stays here because its filings are real, but the feed leaves listed companies out unless you ask for them.

Compare Sign in to watch

What changed

Filed/Approved trial registered: A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

1w agoTrial registeredJul 6, 2026Source filing (opens the source filing in a new tab)

Momentum

77no change

Momentum 77 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Filed/Approved

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    PHASE4 registered

    May 22, 2025

    Multiple Myeloma · RECRUITING · sponsor: Johnson & Johnson Private Limited · A Study to Assess Safety of Teclistamab in Indian Participants With Relapsed and Refractory Multiple Myeloma

    ClinicalTrials.gov · NCT07030517 (opens the source filing in a new tab)

  2. Trial

    PHASE4 registered

    Nov 25, 2020

    Diabetes Mellitus · COMPLETED · sponsor: Johnson & Johnson Private Limited · A Study to Assess Safety of Canagliflozin and Metformin Hydrochloride Combination Given as a Supplement to Diet and Exercise to Improve Blood Sugar Level in Indian Adult Participants With Diabetes

    ClinicalTrials.gov · NCT04288778 (opens the source filing in a new tab)

  3. Trial

    PHASE4 registered

    Jan 7, 2019

    Spondylitis, Ankylosing, Arthritis, Psoriatic · COMPLETED · sponsor: Johnson & Johnson Private Limited · A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis

    ClinicalTrials.gov · NCT03733925 (opens the source filing in a new tab)

  4. Trial

    Study registered

    May 31, 2016

    Prostate Cancer · WITHDRAWN · sponsor: Johnson & Johnson Private Limited · A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

    ClinicalTrials.gov · NCT02608359 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources